Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05GPB
|
||||
Former ID |
DIB002786
|
||||
Drug Name |
Eptacog alfa intravenous
|
||||
Synonyms |
Alfa; Eptacog alfa (GlycoPEGylation, intravenous, hemophilia), Novo Nordisk; Eptacog alfa (GlycoPEGylation, subcutaneous, hemophilia), Novo Nordisk
|
||||
Indication | Hemophilia [ICD9: 286; ICD10:D66-D68] | Phase 1 | [524674] | ||
Company |
Neose Technologies Inc
|
||||
Target and Pathway | |||||
Target(s) | Coagulation factor VII | Target Info | Modulator | [529378] | |
KEGG Pathway | Complement and coagulation cascades | ||||
PANTHER Pathway | Angiogenesis | ||||
Blood coagulation | |||||
PathWhiz Pathway | Coagulation | ||||
Reactome | BMAL1:CLOCK,NPAS2 activates circadian gene expression | ||||
Extrinsic Pathway of Fibrin Clot Formation | |||||
Gamma-carboxylation of protein precursors | |||||
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | |||||
Removal of aminoterminal propeptides from gamma-carboxylated proteins | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.